First Time Loading...

WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 13.9 HKD -1.42% Market Closed
Updated: Apr 13, 2024

Relative Value

The Relative Value of one WuXi Biologics (Cayman) Inc stock under the Base Case scenario is 77.36 HKD. Compared to the current market price of 13.9 HKD, WuXi Biologics (Cayman) Inc is Undervalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
77.36 HKD
Undervaluation 82%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
53
Median 3Y
16
Median 5Y
29.3
Industry
3.9
Forward
3
vs History
98
vs Industry
34
Median 3Y
55.1
Median 5Y
110
Industry
31.8
Forward
12.3
vs History
98
vs Industry
45
Median 3Y
47.8
Median 5Y
95.2
Industry
23.8
vs History
15
vs Industry
6
Median 3Y
-85.8
Median 5Y
-106.8
Industry
26.3
vs History
98
vs Industry
67
Median 3Y
6.4
Median 5Y
9.8
Industry
2.5
vs History
98
vs Industry
58
Median 3Y
15.6
Median 5Y
28.4
Industry
3.9
Forward
2.6
vs History
98
vs Industry
52
Median 3Y
35.4
Median 5Y
66.6
Industry
8.1
vs History
98
vs Industry
41
Median 3Y
45
Median 5Y
86.1
Industry
17.6
Forward
6.5
vs History
98
vs Industry
40
Median 3Y
52.2
Median 5Y
97.9
Industry
23
Forward
8.5
vs History
98
vs Industry
45
Median 3Y
46.4
Median 5Y
91.6
Industry
21.7
vs History
15
vs Industry
16
Median 3Y
-82.8
Median 5Y
-82.8
Industry
27.8
vs History
98
vs Industry
68
Median 3Y
5.9
Median 5Y
10.6
Industry
2.4

Multiples Across Competitors

Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
59.2B HKD 3.2 16.1 10.7 10.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
218.5B USD 5.1 36.5 22.5 33
US
Danaher Corp
NYSE:DHR
177.4B USD 7.4 37.4 25.3 35.7
US
IQVIA Holdings Inc
NYSE:IQV
42.5B USD 2.8 31.3 16.9 26.2
CH
Lonza Group AG
SIX:LONN
38.6B CHF 5.8 59.1 29 29
US
Agilent Technologies Inc
NYSE:A
41.2B USD 6.1 33.4 26.7 32.1
KR
Samsung Biologics Co Ltd
KRX:207940
56.2T KRW 15.2 65.6 34.6 49.8
US
West Pharmaceutical Services Inc
NYSE:WST
27.9B USD 9.5 47.1 32.2 38.5
US
Mettler-Toledo International Inc
NYSE:MTD
27.1B USD 7.2 34.4 24 26.7
IE
ICON PLC
NASDAQ:ICLR
25.2B USD 3.1 41.2 17.5 27.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.1B EUR 8.3 74.6 37.5 56.5

See Also

Discover More